The human papillomavirus (HPV) testing market is growing and will increase at a 16.17% compound annual growth rate until 2019, according to a recent report. The study titled “Global HPV Testing Market 2015-2019” focuses on the present and future scenarios for the market of one the most common methods used to detect cervical cancer.
The report was prepared by Technavio in collaboration with industry experts, presenting a market forecast for the period between 2015 and 2019. To analyze market size, the company studied the sales of HPV testing kits and detection systems, demonstrating the growing prospects of the market in the upcoming years. The analysis is divided by three regions: Americas, Asia and Pacific (APAC), and Europe, Middle-East and Africa (EMEA).
As the major trends in the market of solutions and products the researchers found a comprehensive breakdown of segmentation by key geography. There is a growing incidence of HPV, which is considered the main market driver, as well as an increased prevalence of cervical cancer. The greatest trend is co-testing with both HPV and pap exams, alongside with the emergence of HPV primary screening tests.
Despite market expansion, it still faces the challenge of lack of public awareness conerning the disease and respective exams. Other obstacle is the shortage of alternative diagnostic tests for cervical cancer. In addition to market size and regional analysis, the report also includes key vendors operating and advancing the HPV testing market.
The report emphasizes the role played by Abbott Diagnostics, Hologic Inc., Qiagen NV, and Roche Diagnostics. Other companies cited include Arbor Vita, Becton, Dickinson and Company, Cepheid, Delphi Bioscience, DiaCarta, Diasorin, Fujirebio, Genera Biosystems, IncellDx, OralDNA Labs, Quest Diagnostics, Seegene, Trovagene and Ventana Medical Systems.
HPV is a designation that includes over 200 viruses responsible for infections without symptoms, 40 of them causing highly contagious sexually transmitted diseases. Despite the fact that most HPV infections heal without treatment, those more persistent and severe can cause cervical, penile, anal, vaginal, and oropharyngeal cancers. HPV tests can help prevent the disease by detecting viral genetic material in a cell sample extracted from the cervix.